Original Article(s)
20 March 2025
Vol. 13 (2025)
Antifungal susceptibility of Candida spp. bloodstream isolates identified by real-time polymerase chain reaction: 2022-2023
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
497
Views
150
Downloads
Authors
Background: here are described the antifungal susceptibility patterns of Candida spp. isolates identified by Real-Time Polymerase Chain Reaction (RT-PCR) from positive blood cultures collected from patients hospitalized at the Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo of Alessandria during the period 2022-2023.
Materials and Methods: all patients for whom clinical data were available and from whom blood cultures were collected and were positive only for yeasts, were included in the study. All blood cultures were processed by both Real-Time PCR and classic culture method.
Results: in our case series of 67 blood cultures positive only for yeasts, all isolates were susceptible to echinocandins and amphotericin B. Among the Candida parapsilosis and Candida glabrata isolates, 8/19 (42%) and 2/14 (14.3%), respectively, were resistant to fluconazole.
Conclusions: the rapid identification of the fungal isolate by means of RT-PCR along with the knowledge of the local susceptibility patterns can be of help in choosing the better antifungal therapy until the antimycogram is available.
Altmetrics
Downloads
Download data is not yet available.
Citations
Battistolo J, Glampedakis E, Damonti L, et al. Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital. Mycoses 2021;64:1512-20. DOI: https://doi.org/10.1111/myc.13376
Muderris T, Kaya S, Ormen B, et al. Mortality and risk factor analysis for Candida blood stream infection: a three-year retrospective study. J Mycol Med 2020;30:101008. DOI: https://doi.org/10.1016/j.mycmed.2020.101008
Poissy J, Damonti L, Bignon A, et al. Risk factors for candidemia: a prospective matched case-control study. Crit Care 2020;24:109. DOI: https://doi.org/10.1186/s13054-020-2766-1
Zhang MK, Rao ZG, Ma T, et al. Appropriate empirical antifungal therapy is associated with a reduced mortality rate in intensive care unit patients with invasive fungal infection: A real-world retrospective study based on the MIMIC-IV database. Front Med (Lausanne) 2022;9:952611. DOI: https://doi.org/10.3389/fmed.2022.952611
Pfaller MA, Carroll KC, et al. Manual of clinical microbiology. 13th ed. ASM Press; Washington, DC, USA; 2023.
Spanu T, Posteraro B, Fiori B, et al. Direct MALDI-TOF mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol 2012;50:176-9. DOI: https://doi.org/10.1128/JCM.05742-11
Posteraro B, Torelli R, De Carolis E, et al. Update on the laboratory diagnosis of invasive fungal infections. Mediterr J Hematol Infect Dis 2011;3:e2011002. DOI: https://doi.org/10.4084/mjhid.2011.002
Gaibani P, Rossini G, Ambretti S, et al. Blood culture systems: rapid detection-how and why? Int J Antimicrob Agents 2009;34:S13-5. DOI: https://doi.org/10.1016/S0924-8579(09)70559-X
Paolucci M, Stanzani M, Melchionda F, et al. Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Diagn Microbiol Infect Dis 2013;75:130-4. DOI: https://doi.org/10.1016/j.diagmicrobio.2012.10.012
Mauri C, Consonni A, Briozzo E, et al. Microbiological assessment of the FilmArray Blood culture identification 2 panel: potential impact in critically ill patients. Antibiotics (Basel) 2023;12:1247. DOI: https://doi.org/10.3390/antibiotics12081247
Monti G, Landoni G, Taddeo D, et al. Clinical aspects of sepsis: an overview. Methods Mol Biol 2015;1237:17-33. DOI: https://doi.org/10.1007/978-1-4939-1776-1_3
Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag 2014;10:95-105. DOI: https://doi.org/10.2147/TCRM.S40160
Leli C, Gotta F, Ferrara L, et al. Bayesian estimation of post-test probability of Candida glabrata fungemia by means of serum creatinine. New Microbiol 2022;45:324-30.
BioMérieux Diagnostics. BioFire FilmArray Blood Culture Identification (BCID) panel. Instruction booklet. RFIT-ASY-0126 RFIT-ASY-0127. Available from: https://www.biofiredx.com/support/documents/#toggle-id-4
MERLIN a Bruker Company© MERLIN Diagnostika GmbH. MICRONAUT-AM. Provided by the manufacturer. 2018. Available from: https://www.bruker.com/pl/products-and-solutions/microbiology-and-diagnostics/antimicrobial-susceptibility-testing/micronaut-am.html
Opentrons. Ot-2 robot. 2023. Available from: https://shop.opentrons.com/ot-2-robot/
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs for antifungal agents, version 10.0. 2020. Available from: http://www.eucast.org/astoffungi/clinicalbreakpointsforantifungals/
Pfaller MA, Messer SA, Diekema DJ, et al. Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria. J Clin Microbiol 2014;52:108-14. DOI: https://doi.org/10.1128/JCM.02481-13
Pfaller MA, Diekema DJ, Jones RN, Castanheira M. Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria. J Clin Microbiol 2014;52:3223-9. DOI: https://doi.org/10.1128/JCM.00782-14
Mareković I, Pleško S, Rezo Vranješ V, et al. Epidemiology of candidemia: three-year results from a Croatian tertiary care hospital. J Fungi (Basel) 2021;7:267. DOI: https://doi.org/10.3390/jof7040267
Bourassa-Blanchette S, Biesheuvel MM, Lam JC, et al. Incidence, susceptibility and outcomes of candidemia in adults living in Calgary, Alberta, Canada (2010-2018). BMC Infect Dis 2023;23:100. DOI: https://doi.org/10.1186/s12879-023-08050-0
Pfaller MA, Diekema DJ, Jones RN, et al. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 2002;40:852-6. DOI: https://doi.org/10.1128/JCM.40.3.852-856.2002
Chesdachai S, Baddour LM, Sohail MR, et al. Candidemia in patients with cardiovascular implantable electronic devices: uncertainty in management based on current international guidelines. Open Forum Infect Dis 2023;10:ofad318. DOI: https://doi.org/10.1093/ofid/ofad318
Mahmoud A, Khalid AB, Ehle A, et al. Does heart failure mask Candida tricuspid endocarditis? Cureus 2023;15:e38951. DOI: https://doi.org/10.7759/cureus.38951
Giacobbe DR, Salsano A, Del Puente F, et al. Risk factors for candidemia after open heart surgery: results from a multicenter case-control study. Open Forum Infect Dis 2020;7:ofaa233. DOI: https://doi.org/10.1093/ofid/ofaa233
Alhatmi H, Almansour S, Abanamy R, et al. Clinical characteristics and outcome of candidemia: experience from a tertiary referral center in Saudi Arabia. Saudi J Med Med Sci 2022;10:125-30. DOI: https://doi.org/10.4103/sjmms.sjmms_625_21
Koehler P, Stecher M, Cornely OA, et al. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect 2019;25:1200-12. DOI: https://doi.org/10.1016/j.cmi.2019.04.024
How to Cite
Antifungal susceptibility of Candida spp. bloodstream isolates identified by real-time polymerase chain reaction: 2022-2023. (2025). Working Paper of Public Health, 13. https://doi.org/10.4081/wpph.2025.10062
Copyright (c) 2025 Christian Leli, Lidia Ferrara, Paolo Bottino, Luigi Di Matteo, Marco Leone, Camilla Furiani, Elisabetta Scomparin, Annalisa Roveta, Antonio Maconi, Andrea Rocchetti, Daria Vay, Franca Gotta, Elisa Cornaglia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
